Menthopatch
NDC Package 72602-004-01
Package Information
Menthopatch (menthol , capsicum extract) patches is a medication used as Temporarily relieves minor pain. This formulation utilizes a patch delivery system. Marketed by The Egyptian Saudi Co For Medical Manufacturing Mascomid, this product is identified by NDC 72602-004 and is authorized under FDA application M017.
Identification & Billing
- RxCUI: 2099941 - Capsicum extract 5 % / menthol 4 % Medicated Patch
- RxCUI: 2099941 - Capsicum extract 50 MG / menthol 40 MG Medicated Patch
Clinical Specifications
- Allergens - [CS]
- Cell-mediated Immunity - [PE] (Physiologic Effect)
- Dietary Proteins - [CS]
- Increased Histamine Release - [PE] (Physiologic Effect)
- Non-Standardized Food Allergenic Extract - [EPC] (Established Pharmacologic Class)
- Non-Standardized Plant Allergenic Extract - [EPC] (Established Pharmacologic Class)
- Plant Proteins - [CS]
- Vegetable Proteins - [CS]
Regulatory & Marketing
Hierarchy Structure
- 72602 - The Egyptian Saudi Co For Medical Manufacturing Mascomid
- 72602-004 - Menthopatch
- 72602-004-01 - 5 PACKAGE in 1 PACKAGE / 1 PATCH in 1 PACKAGE
- 72602-004 - Menthopatch
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 72602-004-01 identifies a specific commercial package of 5 package in 1 package / 1 patch in 1 package of Menthopatch Hot, a human over the counter drug labeled by The Egyptian Saudi Co For Medical Manufacturing Mascomid. This patch is formulated for topical use and contains capsicum; menthol as the active substance.
Is this product currently listed with the FDA?
Yes, this product is active and verified within the NDC Directory. It was introduced to the market by The Egyptian Saudi Co For Medical Manufacturing Mascomid on October 25, 2018. The current certification is valid through December 31, 2026.
How is this The Egyptian Saudi Co For Medical Manufacturing Mascomid product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 72602000401. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Product segment to maintain the 5-4-2 structure.